000148398 001__ 148398
000148398 005__ 20240229112702.0
000148398 0247_ $$2doi$$a10.1186/s40425-019-0828-1
000148398 0247_ $$2pmid$$apmid:31806053
000148398 0247_ $$2altmetric$$aaltmetric:72369529
000148398 037__ $$aDKFZ-2019-02953
000148398 041__ $$aeng
000148398 082__ $$a610
000148398 1001_ $$00000-0003-4708-2886$$aWagner, Nikolaus B$$b0$$eFirst author
000148398 245__ $$aTumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies.
000148398 260__ $$aLondon$$bBioMed Central$$c2019
000148398 3367_ $$2DRIVER$$aarticle
000148398 3367_ $$2DataCite$$aOutput Types/Journal article
000148398 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1576240785_12740
000148398 3367_ $$2BibTeX$$aARTICLE
000148398 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000148398 3367_ $$00$$2EndNote$$aJournal Article
000148398 520__ $$aTumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies.
000148398 536__ $$0G:(DE-HGF)POF3-311$$a311 - Signalling pathways, cell and tumor biology (POF3-311)$$cPOF3-311$$fPOF III$$x0
000148398 588__ $$aDataset connected to CrossRef, PubMed,
000148398 7001_ $$aWeide, Benjamin$$b1
000148398 7001_ $$0P:(DE-HGF)0$$aGries, Mirko$$b2
000148398 7001_ $$0P:(DE-He78)20246d15b713462495c9cec21a61c7da$$aReith, Maike$$b3
000148398 7001_ $$0P:(DE-He78)0acd2b06b647ba4fff149a3c0eb463bf$$aTarnanidis, Kathrin$$b4
000148398 7001_ $$0P:(DE-HGF)0$$aSchuermans, Valerie$$b5
000148398 7001_ $$0P:(DE-HGF)0$$aKemper, Charlotte$$b6
000148398 7001_ $$0P:(DE-HGF)0$$aKehrel, Coretta$$b7
000148398 7001_ $$0P:(DE-HGF)0$$aFunder, Anne$$b8
000148398 7001_ $$0P:(DE-HGF)0$$aLichtenberger, Ramtin$$b9
000148398 7001_ $$aSucker, Antje$$b10
000148398 7001_ $$aHerpel, Esther$$b11
000148398 7001_ $$0P:(DE-He78)457c042884c901eb0a02c18bb1d30103$$aHolland-Letz, Tim$$b12
000148398 7001_ $$aSchadendorf, Dirk$$b13
000148398 7001_ $$aGarbe, Claus$$b14
000148398 7001_ $$0P:(DE-He78)38be34240daf8b47325afc7910e77f7b$$aUmansky, Viktor$$b15
000148398 7001_ $$0P:(DE-He78)a229f7724466e7efadf4a1ace1ff8af3$$aUtikal, Jochen$$b16
000148398 7001_ $$0P:(DE-He78)d239d6a28875058b40c13266babadb58$$aGebhardt, Christoffer$$b17$$eLast author
000148398 773__ $$0PERI:(DE-600)2719863-7$$a10.1186/s40425-019-0828-1$$gVol. 7, no. 1, p. 343$$n1$$p343$$tJournal for ImmunoTherapy of Cancer$$v7$$x2051-1426$$y2019
000148398 909CO $$ooai:inrepo02.dkfz.de:148398$$pVDB
000148398 9101_ $$0I:(DE-588b)2036810-0$$60000-0003-4708-2886$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000148398 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000148398 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)20246d15b713462495c9cec21a61c7da$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000148398 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)0acd2b06b647ba4fff149a3c0eb463bf$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000148398 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000148398 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000148398 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000148398 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b8$$kDKFZ
000148398 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b9$$kDKFZ
000148398 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)457c042884c901eb0a02c18bb1d30103$$aDeutsches Krebsforschungszentrum$$b12$$kDKFZ
000148398 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)38be34240daf8b47325afc7910e77f7b$$aDeutsches Krebsforschungszentrum$$b15$$kDKFZ
000148398 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a229f7724466e7efadf4a1ace1ff8af3$$aDeutsches Krebsforschungszentrum$$b16$$kDKFZ
000148398 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)d239d6a28875058b40c13266babadb58$$aDeutsches Krebsforschungszentrum$$b17$$kDKFZ
000148398 9131_ $$0G:(DE-HGF)POF3-311$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vSignalling pathways, cell and tumor biology$$x0
000148398 9141_ $$y2019
000148398 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ IMMUNOTHER CANCER : 2017
000148398 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000148398 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000148398 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central
000148398 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal
000148398 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ
000148398 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review
000148398 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ
000148398 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000148398 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000148398 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000148398 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000148398 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000148398 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bJ IMMUNOTHER CANCER : 2017
000148398 9201_ $$0I:(DE-He78)C060-20160331$$kC060$$lBiostatistik$$x0
000148398 9201_ $$0I:(DE-He78)A370-20160331$$kA370$$lKKE Dermatoonkologie$$x1
000148398 980__ $$ajournal
000148398 980__ $$aVDB
000148398 980__ $$aI:(DE-He78)C060-20160331
000148398 980__ $$aI:(DE-He78)A370-20160331
000148398 980__ $$aUNRESTRICTED